Marshwinds Advisory’s Allergan Inc AGN Stock Holding History

Marshwinds Advisory’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-892	Closed	-$217K	–	140
2017 Q2	$217K	Hold	892	–	–	0.1%	127
2017 Q1	$213K	Buy	+892	New	+$213K	0.1%	128
2016 Q4	–	Sell	-927	Closed	-$213K	–	144
2016 Q3	$213K	Hold	927	–	–	0.1%	132
2016 Q2	$214K	Hold	927	–	–	0.1%	129
2016 Q1	$248K	Hold	927	–	–	0.13%	122
2015 Q4	$290K	Hold	927	–	–	0.15%	115
2015 Q3	$252K	Sell	927 -73	-7%	-$19.8K	0.14%	126
2015 Q2	$303K	Buy	+1,000	New	+$303K	0.15%	117
2015 Q1	–	Sell	-2,700	Closed	-$574K	–	150
2014 Q4	$574K	Hold	2,700	–	–	0.27%	93
2014 Q3	$481K	Sell	2,700 -450	-14%	-$74.7K	0.24%	97
2014 Q2	$533K	Sell	3,150 -50	-2%	-$7.79K	0.26%	96
2014 Q1	$397K	Hold	3,200	–	–	0.2%	105
2013 Q4	$355K	Hold	3,200	–	–	0.19%	108
2013 Q3	$289K	Hold	3,200	–	–	0.17%	115
2013 Q2	$270K	Buy	+3,200	New	+$332K	0.16%	115

Other funds holding AGN

FIM

Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

GIM

Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return

MMPW

Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return

CAM

Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return

Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

GAM

Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return

ARMC

American Research & Management Company Marion, Massachusetts $362M AUM 8.06% 1-Year Est. Return

Marshwinds Advisory's AGN Position: Q3 2017 in Review

Marshwinds Advisory sold out of Allergan Inc (AGN) in Q3 2017, closing a stake of 892 shares — an estimated $217K sold.

Marshwinds Advisory first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $574K in Q4 2014. 10 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

Marshwinds Advisory reported no remaining Allergan Inc position as of Q3 2017 after selling out during the quarter.
Marshwinds Advisory sold 892 Allergan Inc shares in Q3 2017, an estimated $217K.
Marshwinds Advisory first reported a position in Allergan Inc in Q2 2013 and held it in 15 quarters.
Marshwinds Advisory's Allergan Inc position peaked at $574K in Q4 2014.
10 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2017.

Based on Marshwinds Advisory's 13F filing for Q3 2017, filed 6 Oct 2017.